Northern Trust Corp Satsuma Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.7 - $1.07 $27 - $41	-39 Reduced 0.09%	42,193 $29,000
Q4 2022 Feb 13, 2023	SELL	$0.61 - $5.06 $22 - $187	-37 Reduced 0.09%	42,232 $38,000
Q3 2022 Nov 14, 2022	BUY	$4.19 - $7.95 $18,159 - $34,455	4,334 Added 11.42%	42,269 $254,000
Q2 2022 Aug 12, 2022	SELL	$2.59 - $4.3 $2,131 - $3,538	-823 Reduced 2.12%	37,935 $157,000
Q1 2022 May 13, 2022	SELL	$3.78 - $5.32 $1,995 - $2,808	-528 Reduced 1.34%	38,758 $148,000
Q4 2021 Feb 08, 2022	BUY	$4.15 - $6.24 $29,415 - $44,229	7,088 Added 22.01%	39,286 $177,000
Q3 2021 Nov 15, 2021	BUY	$4.54 - $7.17 $35,856 - $56,628	7,898 Added 32.5%	32,198 $150,000
Q2 2021 Aug 13, 2021	SELL	$4.8 - $7.25 $405,292 - $612,161	-84,436 Reduced 77.65%	24,300 $171,000
Q1 2021 May 12, 2021	SELL	$4.57 - $7.18 $63,998 - $100,548	-14,004 Reduced 11.41%	108,736 $642,000
Q4 2020 Feb 11, 2021	SELL	$3.56 - $5.09 $2,969 - $4,245	-834 Reduced 0.67%	122,740 $566,000
Q3 2020 Nov 16, 2020	SELL	$3.85 - $28.47 $13,213 - $97,709	-3,432 Reduced 2.7%	123,574 $481,000
Q2 2020 Aug 14, 2020	BUY	$16.01 - $34.69 $1.09 Million - $2.35 Million	67,852 Added 114.7%	127,006 $3.65 Million
Q1 2020 May 14, 2020	BUY	$14.53 - $30.69 $87,296 - $184,385	6,008 Added 11.3%	59,154 $1.27 Million
Q4 2019 Feb 14, 2020	BUY	$9.32 - $19.68 $430,444 - $908,920	46,185 Added 663.48%	53,146 $1.05 Million
Q3 2019 Nov 13, 2019	BUY	$14.98 - $16.9 $104,275 - $117,640	6,961 New	6,961 $104,000

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.